Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function

Journal of Cell Science

Volumn 117, Issue 9, 2004, Pages 1737-1746

  Cobb, Laura J ^a   Salih, Dervis A M ^a   Gonzalez, Ivelisse ^a   Tripathi, Gyanendra ^a   Carter, Emma J ^a   Lovett, Fiona ^a   Holding, Cathy ^a   Pell, Jennifer M ^a  

^a Signalling Programme   (United Kingdom)

Author keywords

Apoptosis; Cell survival; Insulin like growth factor binding protein 5 (IGFBP 5); Myoblast differentiation; Myogenesis

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CAVEOLIN 3; COMPLEMENTARY DNA; LIPOCORTIN 5; MYC PROTEIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 5;

AMINO ACID SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL STRUCTURE; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; REGULATORY MECHANISM; UPREGULATION; WILD TYPE;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL COUNT; CELL LINE; ENZYME ACTIVATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; INSULIN-LIKE GROWTH FACTOR II; MICE; MUSCLE DEVELOPMENT; MYOSIN HEAVY CHAINS; PROTEIN BINDING; RNA, MESSENGER; TRANSFECTION;

ANIMALIA;

EID: 2342440013     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.01028     Document Type: Article

References (61)

1. Amaar, Y. G., Thompson, G. R., Linkhart, T. A., Chen, S.-T., Baylink, D. J. and Mohan, S. (2002). Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J. Biol. Chem. 277, 12053-12060.
2. Andress, D. (1995). Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells. J. Biol. Chem. 270, 28289-28296.
3. Ashe, P. C. and Berry, M. D. (2003). Apoptotic signaling cascades. Prog. NeuroPsychopharmacol. Biol. Psych. 27, 199-214.
4. Astolfi, A., de Giovanni, C., Landuzzi, L., Nicoletti, G., Ricci, C., Croci, S., Scopece, L., Nanni, P. and Lollini, P.-L. (2001). Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene 274, 139-149.
5. Baserga, R. (1999). The IGF-I receptor in cancer research. Exp. Cell Res. 253, 1-6.
6. Berfield, A. K., Andress, D. L. and Abrass, C. K. (2000). IGFBP-5(201-218) stimulates Cdc42GAP aggregation and filopodia formationin migrating mesangial cells. Kidney Int. 57, 1991-2003.
7. Bergstrom, D. A., Penn, B. H., Strand, A., Perry, R. L. S., Rudnicki, M. A. and Tapscott, S. J. (2002). Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression. Mol. Cell 9, 587-600.
8. Butt, A. J., Dickson, K. A., McDougall, F. and Baxter, R. C. (2003). Insulin-like growth factor binding protein-5 inhibits the growth of human breast cancer cells in vitro and in vivo. J. Biol. Chem. 278, 29676-29685.
9. Butt, A. J., Fraley, K. A., Firth, S. M. and Baxter, R. C. (2002). IGF-binding protein-3-induced growth inhibition and apoptosis do not require cell surface binding and nuclear translocation in human breast cancer cells. Endocrinology 143, 2693-2699.
10. Cain, K., Bratton, S. B. and Cohen, G. M. (2002). The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie 84, 203-214.
11. Cheng, H-L., Shy, M. and Feldman, E. L. (1999). Regulation of insulin-like growth factor-binding protein-5 expression during Schwann cell differentiation. Endocrinology 140, 4478-4485.
12. Clemmons, D. R. (2001). Use of mutagenesis to probe IGF-binding protein structure/function relationships. Endocr. Rev. 22, 800-817.
13. Coolican, S. A., Samuel, D. S., Ewton, D. Z., McWade, F. J. and Florini, J. R. (1997). The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272, 6653-6662.
14. Coverley, J. A. and Baxter, R. C. (1997). Phosphorylation of insulin-like growth factor binding proteins. Mol. Cell. Endocrinol. 128, 1-5.
15. Ding, L., Wang, H., Lang, W. and Xiao, L. (2002). Protein kinase C-epsilon promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway, J Biol. Chem. 277, 35305-35313.
16. Ewton, D. Z., Coolican, S. A., Mohan, S., Chernausek, S. D. and Florini, J. R. (1998). Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: a dual role for IGFBP-5. J. Cell. Physiol. 177, 47-57.
17. Florini, J. R., Magri, K. A., Ewton, D. Z., James, P. L., Grindstaff, K. and Rotwein, P. S. (1991). "Spontaneous" differentiation of skeletal myoblasts is dependent upon autocrine secretion of insulin-like growth factor-II. J. Biol. Chem. 266, 15917-15923.
18. Galbiati, F., Volonte, D., Engelman, J. A., Scherer, P. E. and Lisanti, M. P. (1999). Targeted down-regulation of caveolin-3 is sufficient to inhibit myotube formation in differentiating C2C12 myoblasts. Transient activation of p38 mitogen-activated protein kinase is required for induction of caveolin-3 expression and subsequent myotube formation. J. Biol. Chem. 274, 30315-30321.
19. Green, B. N., Jones, S. B., Streck, R. D., Wood, T. L., Rotwein, P. and Pintar, J. E. (1994). Distinct expression patterns of insulin-like growth factor binding proteins 2 and 5 during fetal and postnatal development. Endocrinology 134, 954-962.
20. Hermisson, M., Wagenknecht, B., Wolberg, H., Glaser, T., Dichgans, J. and Weller, M. (2000). Sensitization to CD95 ligand-induced apoptosis in human glioma cells by hyperthermia involves enhanced cytochrome c release. Oncogene 19, 2338-2345.
21. Hong, H., Zhang, G., Dong, F. and Rechler, M. M. (2002). Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J. Biol. Chem. 277, 10489-10497.
22. Imai, Y., Moralez, A., Andag, U., Clarke, J. B., Busby, W. H. Jr and Clemmons, D. R. (2000). Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions. J. Biol. Chem. 275, 18188-18194.
23. James, P. L., Jones, S. B., Busby, W. H., Clemmons, D. R. and Rotwein, P. (1993). A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J. Biol. Chem. 268, 22305-22312.
24. James, P. L., Stewart, C. E. H. and Rotwein, P. (1996). Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J. Cell Biol. 133, 683-693.
25. Kalus, W., Zweckstetter, M., Renner, C., Sanchez, Y., Georgescu, J., Grol, M., Gemuth, D., Schumacher, R., Dony, C., Lang, K. and Holak, T. A. (1998). Structure of the IGF-binding domain of the insulin-like growth factor-binding protein-5 (IGFBP-5): implications for IGF and IGF-I receptor interactions. EMBO J. 17, 6558-6572.
26. Khan, J., Bittner, M. L., Saal, L. H., Teichman, U., Azorsa, D. O., Gooden, G. C., Pavan, W. J., Trent, J. M. and Melzer, P. S. (1999). cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. USA 96, 13264-13269.
27. Kou, K., Mittanck, D. W., Fu, C. and Rotwein, P. (1995). Structure and function of the mouse insulin-like growth factor binding protein 5 gene promoter. DNA Cell Biol. 14, 241-249.
28. Kuemmerle, J. F. and Zhou, H. (2002). Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates growth and IGF-I secretion in human intestinal smooth muscle by Ras-dependent activation of p38 MAP kinase and Erk1/2 pathways. J. Biol. Chem. 277, 20563-20571.
29. Langley, B., Thomas, M., Bishop, A., Sharama, M., Gilmour, S. and Kambadur, R. (2002). Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J. Biol. Chem. 277, 49831-49840.
30. Lawlor, M. A. and Rotwein, P. (2000). Insulin-like growth factor-mediated muscle cell survival: central roles for Akt and cyclin-dependent kinase inhibitor p21. Mol. Cell. Biol. 20, 8983-8995.
31. Liu, B., Lee, H. Y., Weinzimer, S. A., Powell, D. R., Clifford, J. L., Kurie, J. M. and Cohen, P. (2000). Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J. Biol. Chem. 275, 33607-33613.
32. Marshman, E., Green, K. A., Flint, D. J., White, A., Streuli, C. H. and Westwood, M. (2003). Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells. J. Cell Sci. 116, 675-682.
33. McCaig, C., Perks, C. and Holly, J. M. P. (2002). Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. J. Cell Sci. 115, 4293-4303.
34. Meadows, K. A., Holly, J. M. P. and Stewart, C. E. H. (2000). Tumour necrosis factor-alpha-induced apoptosis is associated with suppression of insulin-like growth factor binding protein-5 secretion in differentiating murine skeletal myoblasts. J. Cell. Physiol. 183, 330-337.
35. Miyake, H., Nelson, C., Rennie, P. S. and Gleave, M. E. (2000a). Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumour model through activation of phosphatidylinositol 3-kinase pathway. Endocrinology 141, 2257-2265.
36. Miyake, H., Pollak, M. and Gleave, M. E. (2000b). Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models. Cancer Res. 60, 3058-3064.
37. Miyakosi, N., Richman, C., Kasukawa, Y., Linkhart, T. A., Baylink, D. J. and Mohan, S. (2001). Evidence that IGF-binding protein-5 functions as a growth factor. J. Clin. Invest. 107, 73-81.
38. Mueller, T., Voigt, W., Simon, H., Fruehauf, A., Bulankin, A., Grothey, A. and Schmoll, H-J. (2003). Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res. 63, 513-521.
39. Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B. A. and Yuan, J. (2000). Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403, 98-103.
40. Niwa, H., Yamamura, K. and Miyazaki, J. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108, 193-200.
41. Pappo, A. S. (1996). Rhabdomyosarcoma and other soft tissue sarcomas in children. Curr. Opin. Oncol. 8, 311-316.
42. Parker, A., Clarke, J. B., Busby, W. H., Jr and Clemmons, D. R. (1996). Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5. J. Biol. Chem. 271, 13523-13529.
43. Pera, E. M., Wessely, O., Li, S-Y. and de Robertis, E. M. (2001). Neural and head induction by insulin-like growth factor signals. Dev. Cell 1, 655-665.
44. Perks, C. M., McCaig, C., Clarke, J. B., Clemmons, D. R. and Holly, J. M. P. (2002). Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells. Biochem. Biophys. Res. Commun. 294, 995-1000.
45. Rajah, R., Valentenis, B. and Cohen, P. (1997). Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism. J. Biol. Chem. 272, 12181-12188.
46. Richman, C., Baylink, D. J., Lang, K., Dony, C. and Mohan, S. (1999). Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140, 4699-4705.
47. Schedlich, L. J., le Page, S. L., Firth, S. M., Briggs, L. J. and Baxter, R. C. (2000). Nuclear import of insulin-like growth factor-binding protein-3 and -5 is mediated by the importin beta subunit. J. Biol. Chem. 275, 23462-23470.
48. Schedlich, L. J., Young, T. F., Firth, S. M. and Baxter, R. C. (1998). Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J. Biol. Chem. 273, 18347-18352.
49. Shand, J. H., Beattie, J., Song, H., Phillips, K., Kelly, S. M., Flint, D. J. and Allan, G. J. (2003). Specific amino acid substitutions determine the differential contribution of the N- and C-terminal domains of insulin-like growth factor (IGF)-binding protein-5 in binding IGF-I. J. Biol. Chem. 278, 17859-17866.
50. Sheikh, M. S., Shao, Z. M., Hussain, A., Clemmons, D. R., Chen, J. C., Roberts, C. T. Jr, LeRoith, D. and Fontana, J. A. (1993). Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. J. Cell. Physiol. 155, 556-567.
51. Stewart, C. E. H. and Rotwein, P. (1996a). Insulin-like growth factor-II is an autocrine survival factor for differentiating myoblasts. J. Biol. Chem. 271, 11330-11338.
52. Stewart, C. E. H. and Rotwein, P. (1996b). Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol. Rev. 76, 1005-1026.
53. Stolf, B. S., Carvalho, A. F., Martins, W. K., Runza, F. B., Btun, M., Hirata, R. Jr, Jordo Neves, E., Soares, F. A., Postigo-Dias, J., Kowalski, L. P. and Reis, L. F. L. (2003). Differential expression of IGFBP-5 and two human ESTs in thyroid glands with goiter, adenoma and papillary or follicular carcinomas. Cancer Lett. 191, 193-202.
54. Tanno, B., Negroni, A., Vitali, R., Pirozzoli, M. C., Cesi, V., Mancini, C., Calabretta, B. and Raschella, G. (2002). Expression of insulin-like growth factor-binding protein 5 in neuroblastoma cells is regulated at the transcriptional level by c-Myb and B-Myb via direct and indirect mechanisms. J. Biol. Chem. 277, 23172-23180.
55. Thrailkill, K. M., Quarles, L. D., Nagase, H., Suzuki, K., Serra, D. M. and Fowlkes, J. L. (1995). Characterization of insulin-like growth factor-binding protein 5-degrading proteases produced throughout murine osteoblast differentiation. Endocrinology 136, 3527-3533.
56. Tsibris, J. C., Segars, J., Coppola, D., Mane, S., Wilbanks, G. D., O'Brien, W. F. and Spellacy, W. N. (2002). Insights from gene arrays on the development and growth regulation of uterine leiomyomata. Fertil. Steril. 78, 114-121.
57. Valentinis, B., Bhala, A., Deangelis, T., Baserga, R. and Cohen, P. (1995). The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol. 9, 361-367.
58. van Loo, G., Saelens, X., van Gurp, M., MacFarlane, M., Martin, S. J. and van den Abeele, P. (2002). The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Diff. 9, 1031-1042.
59. Wu, H., Rao, G. N., Dai, B., Singh, P. (2000). Autocrine gastrins in colon cancer cells Up-regulate cytochrome c oxidase Vb and down-regulate efflux of cytochrome c and activation of caspase-3. J. Biol. Chem. 275, 32491-32498.
60. Xie, X., Zhao, X., Liu, Y., Zhang, J., Matusik, R. J., Slawin, K. M. and Spencer, D. M. (2001). Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer. Cancer Res. 61, 6785-6804.
61. Zestawski, W., Beisel, H-G., Kamionka, M., Kalus, W., Engh, R. A., Huber, R., Lang, K. and Holak, T. A. (2001). The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5. EMBO J. 20, 3638-3644.